Article contents
Commentary: Care, Choice, and the Ethical Imagination
Published online by Cambridge University Press: 22 September 2017
Abstract
- Type
- Departments and Columns
- Information
- Cambridge Quarterly of Healthcare Ethics , Volume 26 , Special Issue 4: Clinical Neuroethics , October 2017 , pp. 698 - 700
- Copyright
- Copyright © Cambridge University Press 2017
References
Notes
1. Netherland J, Hansen H. White opioids: Pharmaceutical race and the war on drugs that wasn’t. BioSocieties 2017;1–22. doi: 10.1057/biosoc.2015.46.
2. Siegler, M. The doctor-patient encounter and its relationship to theories of health and disease. In: Concepts of Health and Disease: Interdisciplinary Perspectives. Reading, MA: Addison-Wesley Publishing Co.; 1981:627–44.Google Scholar
3. Emanuel, EJ, Emanuel, LL. Four models of the physician-patient relationship. JAMA 1992;267(16):2221–6.CrossRefGoogle ScholarPubMed
4. Kahane, G, Ter Meulen, R, Savulescu, J, eds. Enhancing Human Capacities. New York: Wiley-Blackwell; 2011.Google Scholar
5. Allouche, S, Gayon, J, Marzano, M, Goffette, J, (Bateman, S, ed.). Inquiring into Human Enhancement: Interdisciplinary and International Perspectives. New York: Palgrave Macmillan; 2015.Google Scholar
6. Daniels, N. Normal functioning and the treatment-enhancement distinction. Cambridge Quarterly of Healthcare Ethics 2000;9(3):309–22.CrossRefGoogle ScholarPubMed
7. Parens, E. Enhancing Human Traits? Ethical and Social Implications. Washington, DC: Georgetown University Press; 1998.Google Scholar
8. Coveney, CM. Cognitive enhancement? Exploring Modafinil use in social context. Advances in Medical Sociology 2011;13:203–28.CrossRefGoogle Scholar
9. Maher, B. Poll results: Look who’s doping. Nature 2008;452(7188):674–5.CrossRefGoogle ScholarPubMed
10. Ferrari, A, Coenen, C, Grunwald, A. Visions and ethics in current discourse on human enhancement. NanoEthics 2012;6(3):215–9.CrossRefGoogle Scholar
11. Nichter, M. Generation RX: Anthropological research on pharmaceutical enhancement, lifestyle regulation, self-medication and recreational drug use. In: Singer, M, Erickson, PI, eds. A Companion to Medical Anthropology, Blackwell Companions to Anthropology. Malden, MA: Wiley-Blackwell; 2011:338–55.Google Scholar
12. Partridge, BJ, Bell, SK, Lucke, JC, Yeates, S, Hall, WD. Smart drugs ‘as common as coffee’: Media hype about neuroenhancement. PLoS One 2011;(6)11: e28416.CrossRefGoogle Scholar
13. Forlini, C, Partridge, B, Lucke, J, Racine, E. Popular media and bioethics scholarship: Sharing responsibility for portrayals of cognitive enhancement with prescription medications. In: eds. Clausen, J, Levy, N. Handbook of Neuroethics, New York, NY: Springer Dordrecht; 2015:1473–86.Google Scholar
14. Desantis, AD, Hane, AC. ‘Adderall Is definitely not a drug’ justifications for the illegal use of ADHD stimulants. Substance Use & Misuse 2010;45(1–2):31–46.CrossRefGoogle ScholarPubMed
15. Mol, A. The Logic of Care: Health and the Problem of Patient Choice. London: Routledge; 2008.Google Scholar
16. Ilieva, IP, Farah, MH. Enhancement stimulants: Perceived motivational and cognitive advantages. Neuropharmacology 2013;7:198.Google ScholarPubMed
17. Repantis, D, Schlattmann, P, Laisney, O, Heuser, I. Modafinil and Methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research 2010;62(3):187–206.CrossRefGoogle ScholarPubMed
- 1
- Cited by